{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:04:51Z","timestamp":1776989091442,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbrc.2014.08.096","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:18:36Z","timestamp":1409098716000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["miRNA-dependent cross-talk between VEGF and Ang-2 in hypoxia-induced microvascular dysfunction"],"prefix":"10.1016","volume":"452","author":[{"given":"Ruibin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.08.096_b0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-2423(10)50006-4","article-title":"Ocular angiogenesis: mechanisms and recent advances in therapy","volume":"50","author":"Rajappa","year":"2010","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.bbrc.2014.08.096_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000320006","article-title":"Mechanisms of ocular angiogenesis and its molecular mediators","volume":"46","author":"Siemerink","year":"2010","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.bbrc.2014.08.096_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"VEGF and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Saharinen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2014.08.096_b0020","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2014.08.096_b0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.08.096_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.08.096_b0035","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","article-title":"New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF","volume":"18","author":"Holash","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.08.096_b0040","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.08.096_b0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/nature08889","article-title":"MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis","volume":"464","author":"Nicoli","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.08.096_b0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/HCO.0000000000000054","article-title":"Noncoding RNAs in vascular disease","volume":"29","author":"Leung","year":"2014","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.bbrc.2014.08.096_b0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvn156","article-title":"Role of microRNAs in vascular diseases, inflammation, and angiogenesis","volume":"79","author":"Urbich","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2014.08.096_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2011.11.008","article-title":"Cell-specific effects of miR-221\/222 in vessels: molecular mechanism and therapeutic application","volume":"52","author":"Liu","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2014.08.096_b0065","first-page":"1","article-title":"MicroRNAs and ceRNAs: therapeutic implications of RNA networks","author":"Giza","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2014.08.096_b0070","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.cellsig.2013.08.039","article-title":"MicroRNA-dependent cross-talk between VEGF and HIF1alpha in the diabetic retina","volume":"25","author":"Ling","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2014.08.096_b0075","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.bpj.2014.03.040","article-title":"Interactions between distant ceRNAs in regulatory networks","volume":"106","author":"Nitzan","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbrc.2014.08.096_b0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.08.096_b0085","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/db10-1557","article-title":"MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy","volume":"60","author":"McArthur","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2014.08.096_b0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tig.2007.02.011","article-title":"Mechanisms of microRNA-mediated gene regulation in animal cells","volume":"23","author":"Nilsen","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2014.08.096_b0095","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"Gariano","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.08.096_b0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","article-title":"Mediators of ocular angiogenesis","volume":"88","author":"Qazi","year":"2009","journal-title":"J. Genet."},{"key":"10.1016\/j.bbrc.2014.08.096_b0105","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1093\/nar\/gkq570","article-title":"Towards computational prediction of microRNA function and activity","volume":"38","author":"Ulitsky","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2014.08.096_b0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.08.096_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","article-title":"Ocular neovascularization","volume":"91","author":"Campochiaro","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2014.08.096_b0120","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","article-title":"Hypoxic regulation of vascular endothelial growth factor in retinal cells","volume":"113","author":"Aiello","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.bbrc.2014.08.096_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.preteyeres.2012.08.004","article-title":"Role of the retinal vascular endothelial cell in ocular disease","volume":"32","author":"Bharadwaj","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2014.08.096_b0130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/mt.2008.104","article-title":"MicroRNAs regulate ocular neovascularization","volume":"16","author":"Shen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2014.08.096_b0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexmp.2011.04.016","article-title":"MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors","volume":"91","author":"Bai","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2014.08.096_b0140","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1007\/s11033-014-3320-5","article-title":"Long non-coding RNAs: new players in ocular neovascularization","volume":"41","author":"Xu","year":"2014","journal-title":"Mol. Biol. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14015289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14015289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T04:24:43Z","timestamp":1538281483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14015289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0006291X14015289"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.096","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNA-dependent cross-talk between VEGF and Ang-2 in hypoxia-induced microvascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}